Clin2
NCT07609875Possibly a fitNot yet recruiting

Safety study of HS-10522 blood pressure medication in healthy adults

Healthy AdultHypertension

Part of Heart & circulation clinical trials.

This study tests a new experimental blood pressure medication called HS-10522 to see if it is safe and how the body processes it. Researchers will give the medication to healthy adults and those with mild high blood pressure to understand its effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
88 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Be between 18 and 55 years old
  • Weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female, with a normal body mass index (19–28)
  • Have no other medical conditions that affect blood pressure or hormone balance (like thyroid disease or kidney artery problems)
  • Not take any other medications for 2 weeks before starting the study
  • Not have participated in another drug trial in the past 12 weeks
  • Have normal heart rhythm, blood pressure response, and basic lab results

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07644364Recruiting· Phase 1
Blood Pressure Medication Study for Japanese Adults

This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.

Sumida Ku, Tokyo
NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT06790927Not yet recruiting
Standardized blood pressure treatment study

This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.

Shanghai, China
NCT07040046Recruiting· Phase 1
Study of HS-10542 in healthy volunteers

This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.

Qingdao, Shandong
NCT07708441Not yet recruiting· Phase 2/Phase 3
Testing a new pill for hard-to-treat high blood pressure

This trial tests a new medication (HRS-1780) for people whose high blood pressure is not well controlled, even with current treatments. It may help lower blood pressure effectively.

Chongqing, Chongqing Municipality
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.